VYLOY vs XATMEP

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. VYLOY and XATMEP are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	VYLOY	XATMEP
Rating	72/100	72/100
Pharmacy pays	—	~$4.90 /30
Type	RX	RX
Active ingredient	ZOLBETUXIMAB-CLZB	METHOTREXATE SODIUM
Manufacturer	Astellas	Azurity
Dosage forms	Injectable	Solution
Drug class	—	Folate Analog Metabolic Inhibitor
Boxed warning	None	Boxed warning
Half-life	—	about 3 to 10 hours
Treats	Adenocarcinoma, Esophageal Neoplasms	Juvenile Arthritis, Rheumatoid Arthritis, Breast Neoplasms

vyloy xatmep

Rating

72/100

Pharmacy pays

—

~$4.90 /30

Type

Active ingredient

ZOLBETUXIMAB-CLZB

METHOTREXATE SODIUM

Manufacturer

Astellas

Azurity

Dosage forms

Injectable

Solution

Drug class

—

Folate Analog Metabolic Inhibitor

Boxed warning

None

Boxed warning

Half-life

—

about 3 to 10 hours

Treats

Adenocarcinoma, Esophageal Neoplasms

Juvenile Arthritis, Rheumatoid Arthritis, Breast Neoplasms

Frequently asked questions

Which is better-rated, Vyloy or Xatmep?

Vyloy and Xatmep are tied at 3.6 out of 5 by our independent rating.

What is the difference between Vyloy and Xatmep?

Vyloy contains Zolbetuximab-Clzb, while Xatmep contains Methotrexate Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.